USPTO serial 79296821
STRATIFIDEN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- DUBRAY, KATHERINE M
- Law office
- TTAB
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with STRATIFIDEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Biological preparations for medical purposes, namely, preparations for Dengue prognostication; diagnostic reagents for medical use; monoclonal antibody reagents for medical use; tagged antibodies for medical use, namely, preparations for Dengue prognostication; monoclonal antibodies for medical use, namely, reagents for medical diagnosis purposes; immunological antibodies for medical use, namely, immunoassay for medical diagnosis purposes; proteins for medical use in binding antibodies for diagnostic purposes; proteins for medical use in detecting antibodies, for diagnostic purposes; antigens, namely, a group of proteins that are related to severe Dengue; non-medicated serums for Dengue prognostication; immunoassay reagents for medical use, namely, medical diagnostic assays for testing of body fluids and blood; chemical products for immunoassay use, namely, medical monoclonal antibodies, for use in Dengue prognostication; reagents for medical use; test reagents for medical use; chemical test reagents namely, medical diagnostic reagents for testing of body fluids and blood for Dengue prognostication; laboratory reagents for medical use; test reagents for medical diagnosis; chemical reagents for use in medicine; diagnostic reagents for medicinal use; reagents for use in medical diagnosis | ABANDONED | — |
| 010 | Diagnostic testing apparatus for use in immunoassay procedures for medical purposes; medical diagnostic apparatus for Dengue prognostication; diagnostic testing instruments for use in immunoassay procedure for medical purposes; tools for medical diagnostics, namely, the Dengue prognostic test kit; urological diagnostic devices, namely, the Dengue prognostic test kit; medical diagnostic instruments for the analysis of body fluids and blood for Dengue prognostication; medical diagnostic testing apparatus, namely, medical diagnostic apparatus for Dengue prognostication; apparatus for viewing diagnostic test strips, namely, for Dengue prognostic test kit; clinical chemistry analysers for medical use, namely, apparatus for blood fluids and blood analysis for Dengue prognostication; blood testing apparatus; blood testing equipment, namely, absorbance reader for Dengue prognostic test | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 25, 2023 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 4, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 2, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 2, 2022 | MAB4 | ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION | — |
| Dec 2, 2022 | ABN4 | ABANDONMENT - AFTER INTER PARTES DECISION | — |
| Dec 2, 2022 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Dec 2, 2022 | OP.S | OPPOSITION SUSTAINED NO. 999999 | — |
| Sep 20, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 30, 2022 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Aug 25, 2022 | OPNS | OPPOSITION NOTICE (IB REFUSAL) SENT TO IB | — |
| Aug 25, 2022 | OPNC | OPPOSITION NOTICE (IB REFUSAL) CREATED | — |
| May 24, 2022 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Apr 26, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 26, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 24, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 17, 2022 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 6, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 6, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Apr 6, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 30, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 30, 2022 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 24, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 4, 2021 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Sep 4, 2021 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Sep 4, 2021 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jul 21, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 21, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 21, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 21, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 29, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 28, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 9, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 8, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 5, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 30, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 30, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 23, 2020 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Oct 29, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |